SpineTop Stories

Altus Spine Leads as Platinum Sponsors of the Thomas Jefferson University 22nd Annual Spine Fellows Alumni Symposium

West Chester, PA – July 28, 2022 /OrthoSpineNews/ – Altus Spine, a leader in the development and innovation of medical devices used in spinal correction surgery, led as Platinum Level Sponsors at the 22nd Annual Thomas Jefferson University Spine Fellows Alumni Symposium, held July 22nd – July 23RD, 2022, in Newport, RI.

The Altus Team had the opportunity to meet with many recognized attendees who were trained at Thomas Jefferson University, an institute that produces excellence in orthopaedic science and technology.

This highest level of sponsorship exhibits Altus Spine’s commitment to supporting crucial educational programs that continue to benefit surgeons in the field.

“Our team was very pleased to have been able to provide the highest level of sponsorship for this interactive meeting with such renowned TJU Spine Fellow Alumni,” said Michael Fitzgerald, President and CEO, “The 2-day meeting was a huge success and we look forward to supporting similar meetings that provide such great educational opportunities for our surgeons.”

Altus Spine exhibited an array of their innovative portfolio at the meeting including: Fuji Cervical Plate System, Suzuka Cervical IBF System, Sochi OCT System, and the Interlagos Retractor System.

For more information, contact us at info@altus-spine.com 

Altus Spine
Based in West Chester, PA, Altus Spine is dedicated to creating the next generation of medical devices. Altus strives to improve patient care by designing and manufacturing products to meet the highest standards in an ever changing and evolving field. Implemented and used by over 100 hospitals across the United States, Altus is among the fastest growing spinal implant companies in the world. For additional information, or to inquire about distribution opportunities, please contact us at info@altus-spine.com.

Forward Looking Statements
All statements made in the above press release, with the exception of historical fact, may be forward-looking statements that include risk, uncertainty, and assumptions. These factors could cause Altus Spine’s results to differ from those predicted if they do not occur as expected. These uncertain factors include, but are not limited to: acceptance and clearance of the company’s surgical products and procedures, development of new products and procedures, innovations and alterations to existing products and procedures, clinical and statistical verification of the success using Altus Spine’s products, company’s ability to maintain and monitor inventory as it releases new products, its ability to hire and retain personnel, and any other risks stated in prior or subsequent news releases. All risks and potential complications can be found in our most recent 510(k) report from the Food and Drug Administration (FDA). Given the constantly changing market, readers are encouraged to not place undue reliance on forward-looking statements. Altus Spine assumes no obligation to update forward-looking statements as these changes occur, or as events and circumstances are altered, after the date they are posted.


Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button